Cardiac Amyloidosis

Cardiac amyloidosis is a myocardial disease characterized by extracellular amyloid infiltration throughout the heart. Discover the latest research on cardiac amyloidosis here.

September 16, 2021

Transthyretin cardiac amyloidosis.

Medicine and Pharmacy Reports
Raluca TomoaiaDana Pop
September 16, 2021

Screening for hereditary transthyretin amyloidosis in Bulgaria.

Medicine and Pharmacy Reports
Radislav NakovIvailo Tournev
September 16, 2021
Open Access

Dexamethasone is associated with early deaths in light chain amyloidosis patients with severe cardiac involvement.

PloS One
Mélanie BézardThibaud Damy
September 15, 2021

Phase 1a/b Study of Monoclonal Antibody CAEL-101 (11-1F4) in Patients with AL Amyloidosis.

Camille V EdwardsAndrew Eisenberger
September 15, 2021

The genetics of cardiac amyloidosis.

Heart Failure Reviews
Scott Arno, Jennifer Cowger
September 14, 2021
Case Report

Role of imaging for diagnosis and management of aortic valve papillary fibroelastoma and cardiac amyloid light chain amyloidosis: a case report.

European Heart Journal. Case Reports
Ivan DimovPhilippe Unger
September 13, 2021
Case Report

Hypothyroid cardiomyopathy: A reversible phenocopy of hypertrophic cardiomyopathy.

Tomás F CianciulliMarcelo Zylberman
September 13, 2021

The incidence and prevalence of cardiac amyloidosis in a large community-based cohort in Alberta, Canada.

Journal of Cardiac Failure
Nariman SepehrvandJustin A Ezekowitz
September 13, 2021
Comment / Editorial

Recognition and Implications of Undiagnosed Cardiac Amyloid Patients in HFpEF Trials.

JACC. Heart Failure
Richard K Cheng, Mathew S Maurer
September 13, 2021

Spironolactone in Patients With an Echocardiographic HFpEF Phenotype Suggestive of Cardiac Amyloidosis: Results From TOPCAT.

JACC. Heart Failure
Brett W SperryJohn A Spertus
September 11, 2021

Altered stress hormone levels affect in vivo vascular function in the hAPP23+/- overexpressing mouse model of Alzheimer's disease.

American Journal of Physiology. Heart and Circulatory Physiology
Jhana O HendrickxGuido R Y De Meyer
September 10, 2021

What is this image? 2021 image 2 result : The use of 99m technetium-pyrophosphate planar imaging to guide the diagnosis of cardiac amyloidosis.

Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
Gene Iucci, Renee P Bullock-Palmer
September 10, 2021

The Left Ventricular Mass-to-Strain Ratio: Enough to Differentiate ATTR From AL Cardiac Amyloidosis?

JACC. Cardiovascular Imaging
Alberto AimoMichele Emdin
September 10, 2021
Open Access

In Vitro and In Vivo Effects of SerpinA1 on the Modulation of Transthyretin Proteolysis.

International Journal of Molecular Sciences
Filipa BezerraMaria Rosário Almeida
September 10, 2021
Case Report

Familial Amyloidotic Polyneuropathy Type 1: A Hereditary Legacy.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
Joel PintoSusana Cavadas
September 10, 2021
Comment / Editorial

Longitudinal strain in the management of cardiac AL amyloidosis: do we need it?

European Heart Journal
Claudio RapezziRita Pavasini

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused by a partial deletion of chromosome 22. Symptoms include heart defects, poor immune system function, a cleft palate, complications related to low levels of calcium in the blood, and delayed development. Discover the latest research on this disease here.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.


Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Arrhythmogenic Right Ventricular Dysplasia

Arrhythmogenic right ventricular dysplasia is a congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the right ventricle wall and loss of myocardial cells. Primary injuries usually are at the free wall of the right ventricular and right atria resulting in ventricular and supraventricular arrhythmias. Discover the latest research on arrhythmogenic right ventricular dysplasia here.

© 2021 Meta ULC. All rights reserved